Drug–drug interactions between pemafibrate and statins on pharmacokinetics in healthy male volunteers: Open‐label, randomized, 6‐sequence, 3‐period crossover studies

Documents similaires

• Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors
  par: Guihong Yang, et autres
  Publié: (2024)
• Correction to “Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers”
  Publié: (2024)
• Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants
  par: Aarti Sawant‐Basak, et autres
  Publié: (2024)
• Mass balance and pharmacokinetic characterization of zavegepant in healthy male subjects
  par: Rajinder Bhardwaj, et autres
  Publié: (2024)
• Pharmacokinetic interactions between fexuprazan, a potassium‐competitive acid blocker, and nonsteroidal anti‐inflammatory drugs in healthy males
  par: Heejae Won, et autres
  Publié: (2024)